Skip to main content

Part of Cancer staging guidance sheets

Pleural mesothelioma (ICD10 C38.4)

Introduction

This is the data sheet for TNM 9th edition staging of the pleural mesothelioma (ICD10 C38.4)

For more detailed information regarding TNM staging, please see pages 114-117 of the UICC TNM 9 book.


Stage groupings

Stage Group

T stage

N stage

M stage

Stage I

T1

N0

M0

Stage II

T1

N1

M0

 

T2

N0

M0

Stage IIIA

T1

N2

M0

 

T2

N1, N2

M0

 

T3

Any N

M0

Stage IIIB

T4

Any N

M0

Stage IV

Any T

Any N

M1


TNM clinical classification

T - primary tumour

T value

Description

cTX

Primary tumour cannot be assessed

cT0

No evidence of primary tumour

cT1

Tumour limited to the ipsilateral pleura and no involvement of the fissure:

Psum ≤12 mm* and Fmax ≤5 mm**

cT2

Tumour limited to the ipsilateral pleura: Psum ≤12 mm*

With involvement of any of the following:

• Fissure – Fmax >5 mm

• Mediastinal fat invasion

• Solitary area of chest wall soft tissue invasion Or Tumour limited to the ipsilateral pleura, with Psum >12 mm ≤30 mm*

With or without involvement of the following:

• Fissure – Fmax >5 mm

• Mediastinal fat invasion

• Solitary area of chest wall soft tissue invasion

cT3

Tumour limited to the ipsilateral pleura: with Psum >30 mm*

With or without involvement of the following:

• Fissure – Fmax >5 mm

• Mediastinal fat invasion

• Solitary area of chest wall soft tissue invasion

cT4

Tumour involves any of the following:

• Diffuse chest wall soft tissue involvement

• Chest wall with rib involvement

• Mediastinal organs (oesophagus, trachea, heart, great vessels, spine)

• Direct extension through the diaphragm or pericardium

• Direct extension to contralateral pleura

• Malignant pericardial effusion

Notes

*As measured on CT scan

Psum = sum of maximal pleural thickness. Measurements are made on axial images perpendicular to the chest wall or mediastinum in the area of estimated maximal pleural thickness in each third of the hemithorax (pmax1, pmax2 and pmax3) and combined to estimate the total pleural thickness (Psum = pmax1+pmax2+pmax3).

Fmax = maximal pleural thickness along the fissures

N - regional lymph nodes

N value

Description

cNX

Regional lymph nodes cannot be assessed

cN0

No regional lymph node metastasis

cN1

Metastases to ipsilateral intrathoracic lymph nodes (includes ipsilateral bronchopulmonary, hilar, subcarinal, paratracheal, aortopulmonary, paraesophageal, peridiaphragmatic, pericardial fat pad or intercostal and internal mammary nodes)

cN2

Metastases to contralateral intrathoracic lymph nodes. Metastases to ipsilateral or contralateral supraclavicular lymph nodes

M - distant metastasis

M value

Description

cM0

No distant metastasis

cM1

Distant Metastasis


pTNM pathological classification

 

pT -  Primary tumour

pT value

Description

pT1

Tumour limited to the ipsilateral pleura and no involvement of the fissure:

pT2

Tumour limited to the ipsilateral pleura with any of the following:

• the fissure

• ipsilateral lung parenchyma

• non-transmural diaphragm involvement

pT3

Tumour limited to ipsilateral pleura with or without fissure involvement and with invasion of any of the following:

• mediastinal fat

• surface of the pericardium

• endothoracic fascia

• solitary area of chest wall soft tissue involvement

pT4

Tumour involves any of the following:

• diffuse chest wall soft tissue involvement

• chest wall with rib involvement

• mediastinal organs (oesophagus, trachea, heart, great vessels, spine)

• direct extension through the diaphragm or pericardium

• direct extension to contralateral pleura

• malignant pericardial effusion

pN - Regional lymph nodes

The pN category corresponds to the cN category


Download

Click on the box below to download a PDF version of this staging sheet:

Last edited: 16 January 2026 3:47 pm

  1. Cancer staging guidance sheets
  2. Oral Cavity and mucosal lip (ICD10 C00.3-5, C02-C06)
  3. Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C09-14, C30-32)
  4. Pharynx (ICD10 C01, C02.4, C05.1-2, C09, C10.0, C10.2-3, C10.9, C11-13)
  5. Salivary glands (ICD10 C00-C14, C15.0, C30-C33, C41.1)
  6. Oesophagus including oesophagogastric junction (ICD10 C15, C16.0)
  7. Gastrointestinal stromal tumours (ICD10 C15-C20, C48.1-2)
  8. Stomach (ICD10 C16 - excluding C16.0)
  9. Small intestine (ICD10 C17)
  10. Appendix (ICD10 C18.1)
  11. Colon and rectum (ICD10 C18-C20)
  12. Anal and perianal skin (ICD10 C21)
  13. Liver (ICD10 C22.0)
  14. Intrahepatic bile ducts (ICD10 C22.1)
  15. Gallbladder (ICD10 C23)
  16. Distal extrahepatic bile duct (ICD10 C24.0)
  17. Perihilar bile ducts (ICD10 C24.0)
  18. Ampulla of vater (ICD10 C24.1)
  19. Pancreas (ICD10 C25)
  20. Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
  21. Larynx (ICD10 C32.0, C32.1, C32.2, C10.1)
  22. Lung (ICD10 C34)
  23. Thymus tumours (ICD10 C37.9)
  24. Soft tissues (ICD10 C15-C26, C34-C37 C38.1-3, C47-C49, C51-C53, C58, C60-C68)
  25. Bone (ICD10 C40, C41)
  26. Melanoma of skin (ICD10 C00.0-2, C00.6, C21.2, C43, C51, C60, C63.2)
  27. Merkel cell carcinoma of skin (ICD10 C00, C44, C51, C60, 63.2, C80)
  28. Skin carcinoma of the head and neck (ICD10 C00.0-2, C00.6, C44.0, C44.2-4)
  29. Carcinoma of skin of the eyelid (ICD10 C44.1)
  30. Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
  31. Pleural mesothelioma (ICD10 C38.4)
  32. Breast tumours (ICD10 C50)
  33. Vulva (ICD10 C51)
  34. Cervix uteri (ICD10 C53)
  35. Uterine sarcomas
  36. Uterus - endometrium (ICD10 C54.1, C55)
  37. Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
  38. Gestational trophoblastic neoplasms (ICD10 C58)
  39. Penis tumours (ICD10 C60)
  40. Prostate tumours (ICD10 C61.9)
  41. Testis tumours (ICD10 C62)
  42. Kidney tumours (ICD10 C64)
  43. Renal pelvis and ureter tumours (ICD10 C65 & C66)
  44. Urinary bladder tumours (ICD10 C67)
  45. Urethra tumours (ICD10 C68.0, C61.9)
  46. Carcinoma of conjuctiva (ICD10 C69.0)
  47. Melanoma of conjuctiva (ICD10 C69.0)
  48. Retinoblastoma (ICD10 C69.2)
  49. Melanoma of uvea (ICD10 C69.3-4)
  50. Carcinoma of lacrimal gland (ICD10 C69.5)
  51. Sarcoma of orbit (ICD10 C69.6)
  52. Thyroid gland (ICD10 C73.9)
  53. Adrenal cortex (ICD10 C74.0)
  54. Adrenal medulla and extra-adrenal paraganglia (ICD10 C74.1 C75.5)
  55. Parathyroid gland (ICD10 C75.0)
  56. Unknown primary - cervical nodes (ICD10 C77.0)
  57. Mycosis fungoides or sezary syndrome (ICD10 C84.0 and C84.1)
  58. T and B cutaneous lymphoma (ICD10, C82.6, C84.8, C86.6 and other C83-C86 if primary skin excluding C84.0 C84.1)
  59. Rhabdomyosarcoma (CTYA)
  60. Chronic lymphocytic leukaemia
  61. Hepatoblastoma (CTYA)
  62. Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
  63. Medulloblastoma
  64. Multiple myeloma
  65. Neuroblastoma
  66. Neuroendocrine tumours of the foregut
  67. Neuroendocrine tumours of the midgut and hindgut
  68. Non-hodgkin lymphoma (children)
  69. Wilms tumour of the kidney